专门用于脑静脉血栓切除术的专用设备的有效性和安全性:试点随机临床试验
Yi Xu1,2, Yan Wu2,3, Miaowen Jiang4
1Department of Neurosurgery and Neurology (Y.X., B.S., C.L., C.W., J.D., R.M., F.Y., J.C., X.J.), Xuanwu Hospital, Capital Medical University.
Stroke
|November 27, 2024
概括
一种新的血栓切除装置Venous-TD显著改善了接受内血管治疗 (EVT) 的脑静脉血栓症 (CVT) 患者的再通道化率. 这种专用设备还可以减少严重的头痛,而不会增加并发症,因此需要进一步研究.
科学领域:
- 神经学 神经学
- 干预性神经辐射学
- 医疗器械 医疗器械
背景情况:
- 大脑静脉血栓瘤 (CVT) 治疗受到专用血栓切除装置缺乏的挑战.
- 血管内治疗 (EVT) 对CVT的疗效可能受到可用的血栓切除工具的限制.
- 一种新型的NiTi织式支架检索器Venous-TD已被开发为静脉鼻血栓切除术的专用设备.
研究的目的:
- 评估静脉TD装置在患有CVT的患者中的安全性和有效性.
- 为了比较静脉TD的再通道化率和临床结果与标准设备 (Angioguard) 相比.
- 评估EVT后的并发症,功能独立性和头痛严重程度.
主要方法:
- 一项试点,前性,随机,单盲,并行组,单中心临床研究.
- 61名CVT患者被随机分配到使用静脉TD或血管保护器的EVT.
- 主要疗效终点是立即完全重新道化;次要终点包括180天后的功能独立性和头痛;安全性结果也受到监测.
主要成果:
- 与Angioguard相比,静脉TD显著增加了完全再通道化率 (76.7%对20.0%).
- 在180天后,两组之间没有观察到功能独立的显著差异.
- 静脉TD在180天内显著减少严重的残留头痛 (9.7%与35.7%相比),而安全并发症没有增加.
结论:
- 静脉TD装置是安全的,并显著改善了EVT对CVT的再通道化.
- 静脉TD在减少长期严重头痛方面表现出良好的结果.
- 建议进行多中心III期随机试验,以进一步评估静脉TD的疗效和安全性.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...